Overview

A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants

Status:
RECRUITING
Trial end date:
2025-10-20
Target enrollment:
Participant gender:
Summary
This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.
Phase:
PHASE1
Details
Lead Sponsor:
Sagimet Biosciences Inc.
Treatments:
resmetirom